Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-09T09:29:36.592Z Has data issue: false hasContentIssue false

Problems of Pyretotherapy in Paralytic Dementia

Published online by Cambridge University Press:  19 February 2018

H. Wilfred Eddison*
Affiliation:
Wonford House Hospital, Exeter

Extract

Pyretotherapy, or the artificial induction of pyrexia as a means of treatment of the psychoses, has engaged the attention of psychiatrists for many years. The means employed to this end have been numerous, and they may be divided into two classes:

1. Chemical: Hypodermic injections of sodium nucleinate; or of protein in the form of peptone, blood, milk, tuberculin or emulsions of dead bacilli.

2. Infective: The introduction of living organisms, especially Plasmodium vivax malariæ and Spirochete recurrentis duuoni.

Type
Part I.—Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1930 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Dujardin, and Targowla, , “La Thérapeutique de la Paralysie Generale,” Congrès des médecins aliénistes et neurologistes de France et des Pays de langue française, Antwerp, July, 1928.Google Scholar
2 Fildes, and Mcintosh, , “Comparison of Lesions of Syphilis and Parasyphilis,” Brain, 1914, xxxvii, p. 141.Google Scholar
3 Collier, and Adie, , “Syphilis of the Nervous System,” Price's Text-book of the Practice of Medicine, 1928, p. 1441.Google Scholar
4 Bolton, , The Brain in Health and Disease, Arnold, London, 1914.Google Scholar
5 Sabastiani, , “Velocita di sedimentazione e formula leucocitaria nella sifilide cerebrale e nella paralisi progressiva,” Annali Osp. psich. Perugia, 1925.Google Scholar
6 Paoletti, , “Reperti ematologici nei paralitici e terapia malarica,” Policlin., 1928, xxxv, Sez. med., pp. 555557.Google Scholar
7 Skalweit, Wolf (quoted by Paoletti), “Hæmogramm u. Luetin; Reaction bei Impfmalaria,” Inaugural Dissertation Med. Fakult der Hamburg Univ., 1925.Google Scholar
8 Saunders, , “Brain Structure and Blood Changes after Treatment in General Paralysis,” Journ. of Lab. and Clin. Med., 1928, xiii, p. 415.Google Scholar
9 Bruetsch, and Bahr, , Journ. of Nerv. and Ment. Dis., 1928, p. 219.Google Scholar
10 Freeman, , “Malarial Treatment of General Paralysis,” Journ. Amer. Med. Assoc., April, 1927, lxxxviii, pp. 10641068.Google Scholar
11 Hattori, , “Studien über das Blutbild der Impfmalaria bei der Progressiven Paralyse,” Fukuoka-Ikwadaigaku-Zasshi, 1928, xxi, pp. 57.Google Scholar
12 Sträussler, and Koskinas, , Zeitschr. f. d. Ges. Neurol. u. Psychiat., 1925, xcvii, pp. 176191.CrossRefGoogle Scholar
13 Castellani, and Chalmers, , Textbook of Trop. Med., third edition, p. 1320.Google Scholar
14 Piney, , “The Principles of Hæmatological Differentiation,” Journ. Roy. Microscop. Soc., 1926.CrossRefGoogle Scholar
15 McJunkin, , “The Mononuclear and Transitional Leucocytes of Human Blood,” Journ. of Lab. and Clin. Med., 1926–27, xii, pp. 7273.Google Scholar
16 Sagel, , “Die biologischen Leukocytenkurve der Impfrecurrens der Paralytiker,” Zeitschr. f. klin. Med., 1924–25, ci, pp. 499504.Google Scholar
17 Idem, ibid., p. 1150.Google Scholar
18 Alberto, , “Contributo allo studio della formula leucocitaria, del quadro di Arneth e del parassita malarico … nei paralitici,” Giornale di Batteriol. e Immunol., 1927, ii, pp. 295300.Google Scholar
19 Idem, ibid. Google Scholar
20 Kyrle, , Wien. klin. Woch., 1922, No. 42.Google Scholar
21 Zanca, , Arch. de Méd. des Enf., 1926, p. 505.Google Scholar
22 Hoff, , Virchow's Arch., 1926, cclxi.Google Scholar
23 Eddison, H. W., “The Hæmatopoietic Functions in General Paresis,” Journ. Ment. Sci., April, 1929.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.